ResearchDelay in Celiac Disease Diagnosis Among Patients with High-Risk Screening Conditions: Results from a United States Claims Database
ResearchGaps and Disparities in Celiac Disease Screening: A Nationwide Analysis of a High-Risk Pediatric Population
ResearchAbsorption, Distribution, Metabolism, and Excretion of [¹⁴C]-Volixibat in Healthy Men: Phase 1 Open-Label Study
ResearchA Randomised, Double-Blind, Placebo-Controlled Phase 1 Study of the Safety, Tolerability and Pharmacodynamics of Volixibat in Overweight and Obese but Otherwise Healthy Adults: Implications for Treatment of Non-Alcoholic Steatohepatitis
ResearchPRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease
ResearchDevelopment of the Pediatric Daily Ulcerative Colitis Signs and Symptoms Scale (DUCS): Qualitative Research Findings
ResearchDevelopment of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments
ResearchDose-Dependent Effects of Lesogaberan on Reflux Measures in Patients with Refractory Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled Study
ResearchEsophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy
ResearchEffect of Food on the Bioavailability of Lesogaberan Given as an Oral Solution or as Modified-Release Capsules in Healthy Male Volunteers
ResearchEfficacy and Safety of Lesogaberan in Gastro-Oesophageal Reflux Disease: A Randomised Controlled Trial